During the history of vaccine development, a number of adjuvants and a
djuvant formulations have been tested and evaluated for their ability
to increase the immunogenicity of different antigens. In this review,
Anna Lunden, Karin Lovgren Bengtsson, Anders Sjolander and Arvid Uggla
focus on iscoms (immune stimulating complexes), their characteristics
and applications to different types of parasitic antigens.